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V I R O L O G Y
The prefusion structure of herpes simplex virus 
glycoprotein B
B. Vollmer1,2, V. Pražák1, D. Vasishtan1, E. E. Jefferys3, A. Hernandez-Duran4, M. Vallbracht5, 
B. G. Klupp5, T. C. Mettenleiter5, M. Backovic6, F. A. Rey6, M. Topf4, K. Grünewald1,2,7*
Cell entry of enveloped viruses requires specialized viral proteins that mediate fusion with the host membrane by 
substantial structural rearrangements from a metastable pre- to a stable postfusion conformation. This metastability 
renders the herpes simplex virus 1 (HSV-1) fusion glycoprotein B (gB) highly unstable such that it readily converts 
into the postfusion form, thereby precluding structural elucidation of the pharmacologically relevant prefusion 
conformation. By identification of conserved sequence signatures and molecular dynamics simulations, we devised 
a mutation that stabilized this form. Functionally locking gB allowed the structural determination of its membrane- 
embedded prefusion conformation at sub-nanometer resolution and enabled the unambiguous fit of all ectodomains. 
The resulting pseudo-atomic model reveals a notable conservation of conformational domain rearrangements 
during fusion between HSV-1 gB and the vesicular stomatitis virus glycoprotein G, despite their very distant 
phylogeny. In combination with our comparative sequence-structure analysis, these findings suggest common 
fusogenic domain rearrangements in all class III viral fusion proteins.
INTRODUCTION
Herpesviruses present a burden to the general public health as they 
comprise important human pathogens like herpes simplex virus 
(HSV-1), varicella-zoster virus (VZV), Epstein-Barr virus (EBV), and 
cytomegalovirus, the latter being one of the leading viral causes of 
birth defects in developed countries. Still, there is a lack of vaccines 
against most of these pathogens. For all enveloped viruses, specialized 
surface proteins catalyze the fusion of viral and cellular membranes 
for entry (1) and also represent a primary target for the immune 
system. There are three structural classes of viral membrane fusion 
proteins, but they all appear to function via a similar mechanism de-
spite their radically different three-dimensional structures. Membrane 
merging is achieved via substantial structural rearrangements of these 
proteins from a metastable pre- to a stable postfusion conformation. 
The prefusion form presents an attractive target for drug and vaccine 
development as demonstrated for the class I fusion protein F of re-
spiratory syncytial virus (RSV), for which the most potent neutraliz-
ing antibodies target this conformation only (2). Identifying ways to 
stabilize the prefusion conformation of RSV F has been a major ad-
vance in the development of surface epitope-focused, next-generation 
vaccines (3, 4). Herpesvirus glycoprotein B (gB) is a structurally 
conserved, class III membrane fusion protein, composed of - and 
-secondary structure elements, that combines structural features 
characteristic of class I and II fusion proteins (5). Although the gB post-
fusion conformation was determined more than 10 years ago (6), 
only recently first descriptions of the prefusion form were reported 
(7, 8). Attempts to determine high-resolution structures by crystal-
lization or single-particle analysis electron cryo microscopy (cryo-EM) 
failed because of its metastability, causing it to readily adopt the 
postfusion conformation when using purification methods involving 
membrane anchor or lipid removal (9). Even on native membranes, 
mixtures of full-length gB trimers present in either pre- or postfusion 
conformations are found (7, 10). Stabilization of gB in the prefusion 
conformation allowing determination of its structure and compre-
hensive domain model will greatly assist structure-based drug design 
and antibody generation. Here, by using a molecular dynamics (MD) 
simulations and sequence-structure analysis guided mutational ap-
proach, we successfully trapped the prefusion conformation of gB and 
determined its structure to sub-nanometer resolution by electron cryo 
tomography (cryo-ET) and sub-volume averaging (SVA). The 
quality of the cryo-ET map allowed an unambiguous description 
of the domain arrangements, highlighting the substantial struc-
tural changes required to drive the membrane fusion reaction and a 
notable resemblance to the conformational changes described for 
vesicular stomatitis virus glycoprotein G (VSV-G).
RESULTS
A conserved hinge in DIII of gB
gB of the double-stranded DNA (dsDNA) herpesvirus HSV-1 and 
glycoprotein G of the single-stranded RNA (ssRNA) rhabdovirus VSV 
are the archetypic members of class III fusion proteins (6, 11). Like 
all known members of this class, these are single membrane–spanning 
proteins that form trimers. Despite belonging to evolutionary seemingly 
unrelated virus families, the arrangement and structure of their in-
dividual domains are conserved (Fig. 1, A and B), but high-resolution 
structures for the prefusion form are only available for two rhabdovirus 
glycoproteins (12, 13). In the postfusion conformation (Fig. 1A), 
domain I (DI) of gB is mainly formed by  sheets, exposing the fu-
sion loops that insert into the target membrane (6, 14, 15). Moving 
away from the membrane, the polypeptide chain then folds into do-
main II (DII), which consists of  helices and  sheets, continuing 
into domain III (DIII) that features a prominent, centrally located  
helix and forms a long trimeric parallel coiled-coil at the center of 
the gB trimer. At the top of the protein is the globular domain IV 
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(DIV), followed by an extended segment, domain V (DV). The latter 
runs along the entire trimer down to the membrane-proximal re-
gion (MPR) and membrane anchor located at the same end as the 
fusion loops. In VSV-G, a similar arrangement is formed by con-
served, but shorter, domains with gB DV being substituted in VSV-G 
by a mostly disordered stem region leading straight into the MPR 
(Fig. 1B).
Comparative analyses of the pre- and postfusion structures of 
VSV-G (11, 12) revealed that its conformational transition is largely 
achieved by interdomain rotations, occurring mainly between the 
fusion domain (FD) containing the fusion loops and the pleckstrin 
homology domain (PHD), and a notable refolding of the region 
N-terminal to the central domain (CD), corresponding to the C ter-
minus of DIII and DIV in gB [Fig. 1, A (insets) and B] (5, 16). In the 
prefusion conformation of VSV-G, the central helix consists of a 
310-helix (amino acids 269 to 271) oriented perpendicular to the 
-helical region immediately downstream (amino acids 275 to 293) 
(12), the two being connected via a short hinge (amino acids 272 
to 274; Figs. 1, A and C, and 2A). In the postfusion form, the en-
tire region (amino acids 263 to 294) refolds into a single, long  
helix that subsequently forms the central coiled-coil of the trimer 
(Figs. 1A and 2A).
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Fig. 1. Determination of a conserved hinge in DIII of gB. (A) Trimeric ectodomain x-ray structures of gB in postfusion (6) and VSV-G in postfusion (11) and prefusion (12) 
conformation. Corresponding domains are depicted using the same color scheme for a single protomer. The central helices of each of the protomers are magnified and 
displayed in insets. The hinge regions in gB RHV515–517 and VSV-G IQD272–274 are marked in striped green and the 310-helix VSL269–271 in red. Location of fusion loops is marked 
for one protomer. Domains are named according to (6) for gB and (16) for VSV-G. CD, central domain; PHD, pleckstrin homology domain; FD, fusion domain. (B) Domain 
architecture of gB and VSV-G. Numbers indicate amino acid positions of the domain boundaries. N-terminal signal peptides and the unstructured N-terminal domain of gB 
are shown in white, and flexible linker regions are shown in purple. CTD, C-terminal domain. (C) Sequence alignment of central helices of glycoprotein G [domain II (DII)] of 
Rhabdoviridae and glycoprotein B (DIII) of human Herpesviridae. The consensus secondary structure of the central postfusion coiled-coil helix of VSV (11) and HSV-1 (6) is 
shown in between the alignment of the two virus families. The color outlining the helix indicates the length of the helix of VSV-G (purple) and HSV-1 gB (orange), respective-
ly, while the dashed outline marks the linker region to the C-terminally attached short helix. The residues forming the N-terminal 310-helix of the prefusion VSV-G structure 
are shown in red letters, and the hinge region residues of the same structure as well as the putative hinge in HSV-1 gB are shown in green letters. Residue background 
coloring is based on Clustal Omega (39), and conservation was calculated using www.compbio.dundee.ac.uk/aacon/ (40). Three highly conserved, sequence signatures are 
marked by asterisks on the bottom of the alignment. VHSV: viral hemorrhagic septicaemia virus; RABV: rabies virus; BEFV: bovine ephemeral fever virus; SIGV: Drosophila 
melanogaster sigma virus; VZV: varicella zoster virus; EBV: Epstein-Barr virus; HHV8: Kaposi’s sarcoma-associated herpesvirus; HHV6: human herpesvirus 6; HHV7: human 
herpesvirus 7; HCMV: human cytomegalovirus.
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Even though the domain containing this central helix shows a high 
diversity in sequence and length between class III fusion proteins, 
we identified three sequence signatures occurring in fusion proteins 
of the families Rhabdoviridae and Herpesviridae (Fig. 1C): (i) an L 
or I residue located at the N terminus of the central helix; (ii) a con-
served cysteine residue forming a disulfide bond; and (iii) a K 
( indicating a hydrophobic residue) combination toward the C ter-
minus of the -helical part, which is followed by a linker and a short 
 helix, kinked away from the main helix (Fig. 1A). Notably, in 
VSV-G, the highly conserved leucine of the first signature is located 
at the edge of the 310-helix, the segment that undergoes refolding 
during the pre- to postfusion transition. We therefore focused on 
the corresponding region in DIII of gB.
MD simulation of DIII in solution
To test whether the N-terminal part of the central helix is also im-
portant for the pre- to postfusion transition in HSV-1 gB and to 
pinpoint specific residues involved, we performed MD simulations 
using a “reverse engineering” in silico approach, starting from the 
long central helix (DIII) of the gB postfusion form (Fig. 1A). In two 
independent 100-ns MD simulations, a hinge readily formed after 
10 and 9 ns, respectively, and remained stable for the rest of the 
simulations (movie S1). In plots of the local bending angle, this 
hinge can be identified as peak in the simulated helix similar to the 
prefusion conformation of VSV-G (Fig.  2A), suggesting that the 
hinge region in gB is located within residues 515 to 517 (Fig. 2B).
Locking the gB prefusion conformation
On the basis of this finding, we tried to stabilize the DIII central 
helix hinge and, thus, the prefusion form of gB. Previous attempts 
to do so, by mutations or short linker insertions in DIII (17, 18), 
have failed and only yielded the postfusion conformation. Here, we 
combined an approach successfully applied to stabilize class I fusion 
proteins in their prefusion form (4, 19–21) with our method to display 
full-length, membrane-anchored gB on extracellular vesicles (22). 
For this, we introduced helix-breaking point mutations to proline 
into the MD-predicted helix hinge at residues 515 to 517 of gB 
(Figs. 2B and 3A). This proline scanning resulted in wild type (WT)–
like expression of full-length mutant gB only with a proline at position 
516 (Fig. 3A). Mutations in adjacent positions resulted in low or no 
expression of mature protein and absence of vesicles (Fig. 3A). Notably, 
mutations in the corresponding VSV-G hinge region (amino acids 272 
to 275) between the 310 and the downstream  helix were also tolerated 
in one position (Q273) only (fig. S1, A and B). The amount and ra-
tio of fully to partly glycosylated gB on extracellular vesicles, detect-
able as a single or double band, respectively (23), were not altered by 
the H516P mutation, suggesting that expression and posttransla-
tional modifications were not affected (Fig. 3A).
Locked gB is functionally arrested
We then tested the fusion activity of gB H516P in a cell-cell fusion 
assay (24) in the presence of gD, gH, and gL. All four glycoproteins 
are essential and sufficient for HSV-1 membrane fusion and entry 
(25, 26). Compared to wt gB, the cell-cell fusion activity of gB H516P 
was reduced to 6.5% (SD: 3.2%) (Fig. 3B), only slightly above the 
background level [1.6% (SD: 1.4%)] of a fusion-null construct (27, 28). 
This fusion inhibition is consistent with a block in the pre- to post-
fusion state transition, functionally locking the protein.
Displaying locked gB on native membranes
As we reported earlier, wt gB is present in two major forms on ex-
tracellular vesicles (Fig. 3C) (7): an extended one (~16 nm in length), 
corresponding to the postfusion conformation and mostly found on 
small vesicles ( ~ x Ø = 59 nm), and a compact one (~12 nm), presum-
ably corresponding to the prefusion state, found on larger vesicles 
( ~ x Ø = 98 nm) (Fig. 3, C and D). For wt gB, about 30% of vesicles 
predominantly presented the extended form, while 70% predomi-
nantly presented the compact form (n = 183), similar to previous 
observations (7).
For gB H516P, total vesicle production was similar to wt gB 
(Fig. 3A), but the ratio was drastically shifted to 98.2% (n = 112) of 
vesicles displaying solely the compact form and only 1.8% displaying 
the extended form (n = 2), with comparable size distributions as the wt 
vesicles ( ~ x Ø = 53 nm for extended form;  ~ x Ø = 90 nm for compact 
form) (Fig. 3D). Thus, introducing the H516P mutation apparently 
inhibited the transition of gB from the compact to the extended 
form. The small number of vesicles displaying the extended form of 
gB H516P parallels the remaining residual fusion activity, which is 
marginally above background levels (Fig. 3B). Notably, a gB H516P 
ectodomain construct (amino acids 31 to 730) lacking the MPR 
and transmembrane anchor crystallized in the postfusion con-
formation (fig. S2) corroborating the intrinsic propensity of gB ecto-
domain to easily adopt its postfusion form and the importance of 
the membrane anchor in maintaining the prefusion conformation.
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Fig. 2. MD simulation of DIII in solution. (A) Local bending angles of VSV-G DII in prefusion (yellow) (12) and postfusion (blue) (11) conformation. Protein Data Bank 
(PDB) numbers are given in parentheses. Amino acids are given in one-letter code. The 310-helix and hinge region are highlighted by dashed boxes in red and green, re-
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Structure of the locked gB
Next, purified vesicles displaying the H516P gB variant were struc-
turally analyzed using cryo-ET and SVA. Earlier respective attempts 
were limited by the conformational flexibility (“breathing”) of the 
compact wt gB form. The relative homogeneity of the stabilized gB 
H516P protein on the vesicles greatly facilitated particle picking and 
averaging (Fig. 3, C and D). A total of 46,067 sub-volumes contributed 
to the final map (Fig. 4A) (Supplementary Materials) resolving the 
gB ectodomain at an overall resolution of 9 Å (fig. S3, A and B). This 
represents a substantial improvement in the level of structural detail 
compared to previous prefusion structures ranging in resolution 
from ~21 to 50 Å (7, 8, 10). The resolved ectodomain has clear C3 
symmetry with overall dimensions of ~12 nm in height and ~10 nm 
in width. A three-pointed density (“crest”) crowns the membrane- 
connected trimer. Slices through the volume reveal a funnel-like 
arrangement of the crest (Fig. 4A, panels a to c). The lower part of 
the trimer is dominated by three major densities (“legs”) protruding 
laterally (Fig. 4A, top view, white arrowheads, and panels d to f), 
which frequently form interfaces with neighboring gB trimers (fig. S4) 
(7). These lateral interactions seem to be flexible, allowing the for-
mation of pentameric, but also hexameric, arrangements on the mem-
brane surface (fig. S4A). Most notably, particularly well-resolved rod- 
like densities (fig. S3A), with a diameter of ~8 Å and therefore most 
likely representing  helices, are located at the center of the trimer 
(Fig. 4A, panels e to g). A slice at the phospholipid headgroup level 
of the outer membrane leaflet reveals parts of the protein embedded 
in the membrane or connected to it (Fig. 4A, panel h).
Domain architecture of the pre- and  
postfusion conformation
The resolution of our SVA map allowed the reliable placement of 
each individual domain of the gB ectodomain x-ray structure (6, 14) 
by rigid-body fitting (29) and subsequent optimization by MD-based 
flexible fitting [Figs. 4 (B to E) and 6, and table S1] (30). The resulting 
model occupied essentially the complete density of the map (movie S2). 
The order of fitting the individual domains is depicted in movie S2 
starting with DIV (orange), which forms the crown domain in the 
postfusion conformation (Fig. 1A). This domain showed the best fit 
being docked upside down, in relation to the membrane, into a fist-
shaped density (table S1), located about 2 nm from the membrane 
(Fig. 4, B and C). This assignment placed DIII (yellow) in the central 
rod density. The short, kinked C-terminal helix of DIII (Fig. 1, A and C) 
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Fig. 3. Locking and functionally arresting the gB prefusion conformation. (A) SDS–polyacrylamide gel electrophoresis (PAGE) and Coomassie stain of extracellular 
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fusion activity level. (C) Cryo-ET slices of purified extracellular vesicles formed by WT and gB H516P. The long, postfusion form of gB is indicated by blue lines, and the short 
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fits well into the density that makes the connection between the 
central rod and DIV (Fig. 4C). At the top, the N terminus of DIII is 
connected to DII (green) via a flexible, ~3-nm-long linker region, 
predicted to form an unstructured poly-proline loop that was not 
resolved in the crystal structures (6, 14). This connectivity led us to 
place DII in the crest density (Fig. 4, B and D). An alternative fit in 
the “leg” density would have required a longer linker length of at 
least 5 nm. DI (blue) was fitted in the leg density, connected to DII 
and leading to the membrane, localizing the fusion loops pointing 
toward the membrane (Fig. 4, B and C). The postfusion x-ray struc-
ture of gB shows a  hairpin in DI, perpendicular to the  hairpins 
exposing the fusion loops, for which no corresponding densities 
were resolved in our map (Fig. 4, B and C, red arrowheads). Notably, 
comparing the location of this  hairpin in gB of other herpesviruses 
showed some flexibility in relation to the rest of DI (31), indicating 
a possible conformational rotation that would place it inside our 
density map. This change could be due to subtle differences in DI 
between the pre- and postfusion conformations, which could explain 
why visually this fit appears not as good as those for DII to DV (Fig. 4, 
B and C). The central, tubular density leading toward the mem-
brane most probably represents the previously unresolved DV (Fig. 4, 
C and E), which connects DIV with the MPR and transmembrane 
domain (TMD) helices (Fig. 4C). The close, ~1.5-nm-spaced ar-
rangement of the three DV seen at the center of the map (Fig. 4A, 
panel g), compared to the ~3.6-nm distance in the postfusion structure 
(Figs. 1A and 5) (14), suggests an extensive reorientation of the con-
nected amphipathic helices of the MPR discernible in our map 
(Fig. 4A, panel h, and fig. S5A). Because of the ~28–amino acid–long 
unresolved linker connecting DV to the MPR, two arrangements 
are possible, placing the TMD connections at different distances 
(~2.5 versus ~0.8 nm) from the molecular threefold symmetry axis 
(fig. S5A). An earlier study (32) suggested that the MPR amphipathic 
helices might function in shielding the fusion loops from the membrane 
in the prefusion conformation. On the basis of our sub-nanometer– 
resolution density map and rigid-body fitting, these two structural 
elements are too distant from each other to support this hypothesis. 
SVA further revealed, albeit at lower resolution, both membrane 
leaflets and a globular density underneath, connected via three dis-
tinct membrane contact points (fig. S5B). The latter density indicates 
the position of the cytoplasmic C-terminal domain (CTD) (14), which 
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has been suggested to regulate gB fusogenicity (33). However, given 
the lower resolution of the map in this region, any density fitting of 
structural elements is still speculative (fig. S5B).
DISCUSSION
The arrangement of secondary structure elements resulting from 
rigid fitting of the ectodomains I to IV accounts for the features re-
solved in the ectodomain EM map remarkably well (Fig. 4, B to D; 
table S1; and movie S2), although DI appears to undergo partial re-
arrangement during the fusogenic transition, which could place the 
 hairpin inside the resolved density. Fitting of DI into the density 
contacting the membrane is in contrast to our previous work where, 
using a 23-Å resolution map of gB (7), we placed DI at the top of the 
structure. The lower resolution of the former map is most probably 
due to the smaller number of sub-volumes but could also be caused 
by a higher flexibility of the protein. The model, arrived at through 
extensive comparison of many fits from multiple density fitting 
methods, placed the fusion loops at the top of the structure, facing 
away from the membrane. The here-presented EM map reveals den-
sities in the center of the map (Fig. 4A), not seen previously, and the 
improved resolution now allows unambiguous fitting of DII to DIV. 
The connectivity of the domains therefore places DI pointing to the 
membrane as proposed for VSV-G (12). The previous model based 
on the wt gB protein likely consists of a large subset of conforma-
tional states. With a similar approach using cryo-ET on gB vesicles, 
Fontana et al. (8) obtained a map with a resolution of ~50 Å. The 
resolution of this map would have allowed both positions for DI to 
be possible, but combination of the inconclusive EM density with 
biochemical data, using monoclonal antibodies, led the authors to 
position DI pointing to the membrane reinforcing a previous, hypo-
thetical model devised by fluorescent protein insertions (34). A recent 
cryo-EM map from SVA of human cytomegalovirus (HCMV) par-
ticles allowed determination of a prefusion conformation of HCMV 
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gB at ~21-Å resolution (10). In contrast to our previous density map 
for HSV-1 gB showing a three-pointed crest at ~23-Å resolution, 
the HCMV gB map features a single central density at the top of the 
structure. This central density precludes fitting of DI at the top as this 
would lead to clashes within the trimer, and therefore, DI was fitted in 
the leg density pointing to the membrane. Our sub-nanometer– 
resolution map presented here now permits the unambiguous fit of 
all HSV-1 gB ectodomains, including DI pointing to the membrane 
(Figs. 5 and 6, and table S1), in agreement with the interpretation 
suggested by these studies (8, 10).
The resolved density at the center of the map allowed placing of 
the complete DIII helix (Fig. 1A). However, fitting of the N-terminal 
part of the central helix of DIII (amino acids 515 to 545) located 
around the predicted bending point is challenging. The resolved 
density in the center of the EM map would accommodate the whole, 
unbroken helix, and our MD-based flexible fitting approach (30) 
suggests a kink near the predicted bending position at the N-terminal 
end of the helix, which would agree with a model for HCMV gB 
(10) but would be different from the hinge present in VSV-G and 
the strong local bending predicted by our MD simulation (Fig. 2). 
The central helix of DIII in gB of Herpesviridae contains a 9–amino 
acid insertion (Fig. 1B), which makes this helix substantially longer 
compared to the corresponding helix in VSV-G, also in the prefusion 
conformation, which would account for part of the density in the 
upper region of the map. Nevertheless, fitting the N-terminal region of 
this helix suffers from several issues: the low resolution of the EM map 
in this area, the 15–amino acid (476 to 491) linker region that is un-
resolved in the crystal structure, and the fact that this region likely 
undergoes an extensive local conformational change. It therefore remains 
to be determined to what extent the N-terminal part of this helix is bent.
DV, which is intrinsically less structured than DI to DIV, required 
substantial rearrangement, but the assignment is supported by con-
nectivity to the membrane. Because of the overall quality of the fit, 
we assume that most of conformational changes between the pre- 
and postfusion form occur, as described for VSV-G, at interdomain 
connections rather than intradomain changes (35, 36). The domain 
arrangement resulting from our domain fitting of gB resembles that 
of VSV-G in its prefusion conformation (Fig. 5) (12), although in 
gB, DIV is cyclically swapped within the trimer, making contacts 
with neighboring protomer subunits, while for the CD of VSV-G, 
such domain swapping does not occur (Fig. 5, top views). In VSV-G, 
comparing the pre- and the postfusion conformation, the FD and 
the C-terminal segment, which makes the connection to the trans-
membrane domain, flip around the CD, illustrating the relative do-
main rearrangement that occur during the fusion process (Fig. 5) 
(35). The domain rearrangement between the two conformations in 
gB follows a similar pattern. Here, DI, DII, and DV flip around the 
central part of the protein including the C-terminal region of DIII 
and DIV. In VSV-G, the CD stays essentially unchanged, and our 
model also predicts only minor changes for DIV and the C-terminal 
region of DIII during this transition in gB. In context of the gB 
trimer, the N-terminal regions DI and DII twist around the central 
axis of the trimer, which is not seen in VSV-G where there is hardly 
any lateral movement of the FD (Fig. 5, top views). Nevertheless, the 
general domain architecture of the ectodomains in the two conforma-
tions shows notable similarities that further corroborate the previously 
described homology (37) of these two proteins and the suggestion 
that these proteins evolved from a common ancestor. Other than 
VSV-G that fuses the viral membrane with the endosome membrane 
of the host only, gB can also fuse the HSV-1 envelope with the plasma 
membrane. The fact that both proteins accomplish their membrane 
fusion function in different contexts might explain the different trig-
gering requirements (35) with VSV-G being activated by the low pH 
of the endosome, while HSV-1 gB fusion by low pH is not sufficient. 
For gB fusion, triggering seems more complex and regulated and is 
only possible as part of a four-protein machinery together with gD and 
gH/gL (38). The essential features of the conformational change—once 
triggered—have remained very similar.
The structural features we identified and exploited to lock gB are 
conserved in class III fusion proteins of other relevant pathogens, 
opening a path to stabilize their prefusion conformation and sug-
gesting common structural rearrangements during fusion. Antibodies 
or antiviral drugs impairing this general rearrangement therefore 
have the capacity to achieve clinically relevant protection. Our results 
provide the first step for the rational design of prefusion epitope- 
focused, next-generation vaccines against important human patho-
genic herpesviruses.
MATERIALS AND METHODS
Sequence alignment
Clustal Omega (39) was used to calculate the sequence alignment of 
central helices of glycoprotein G (DII) of animal Rhabdoviridae and gB 
(DIII) of human Herpesviridae with genus or subfamily representatives 
of the novirhabdoviruses [viral hemorrhagic septicemia virus (VHSV)], 
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Fig. 6. Domain architecture of the pre- and postfusion conformation. Structure of 
the rigid-body fit for the prefusion conformation in comparison to the full-length 
postfusion structure. Domains are marked and colored as in (14), also indicating 
representative positions of potential N-linked glycosylations. Two protomers per 
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the lyssaviruses [rabies virus (RABV)], the ephemeroviruses [bovine 
ephemeral fever virus (BEFV)], the unclassified sigma virus of 
Drosophila (SIGV), and the vesiculoviruses [vesicular stomatitis indiana 
virus (VSV)], -herpesviruses (human HSV-1 and VZV), -herpes-
viruses [EBV and Kaposi’s sarcoma-associated herpesvirus (HHV8)], 
and -herpesviruses [human herpesvirus 6 (HHV6), HHV7, and HCMV]. 
Clustal Omega (39) was also used for the residue background color-
ing, which corresponds to conserved hydrophobic (blue), positively 
charged (red), negatively charged (magenta), polar (green), cysteines 
(pink), glycines (orange), prolines (yellow), aromatic (cyan), and 
unconserved (white) residues. Residue conservation was calculated 
using www.compbio.dundee.ac.uk/aacon/ (40).
Expression plasmid construction
The sequence for a 5xGS linker was added to the C terminus of the 
gB gene, followed by a 6xHis tag in the pEP98 plasmid. The gene for 
VSV-G (strain San Juan) was amplified by polymerase chain reac-
tion and inserted into the modified pEP98 vector, replacing gB. Single- 
point mutations were created using the Agilent QuikChange II Kit 
or NEB Q5 kit for site-directed mutagenesis.
Vesicle preparation
Vesicles were prepared as described (22). In brief, BHK-21 cells were 
grown in GMEM (Glasgow’s Minimal Essential Medium) supplemented 
with 20 mM Hepes (pH 7.4), 2% (v/v) TPB (tryptose phosphate broth), 
and 2% (v/v) fetal bovine serum. At around 70% confluency, cells 
were transiently transfected. Cells were grown for an additional 48 hours 
with a media exchange to serum-free GMEM after 24 hours. Vesicles 
were harvested from the supernatant by differential centrifugation 
and resuspended in 20 mM Hepes (pH 8) and 150 mM NaCl.
Expression tests
Vesicle preparations were tested in SDS–polyacrylamide gel electro-
phoresis (PAGE) followed by Coomassie staining or Western blot-
ting with a rabbit anti-His6 antibody (Abcam) followed by anti-rabbit 
horseradish peroxidase (HRP) (Sigma-Aldrich Chemie GmbH). After 
supernatants were removed for vesicle preparations, cells were washed 
with cold phosphate-buffered saline (PBS) and detached using cell 
scrapers. Cells were pelleted by centrifugation (5 min, 4500g, 4°C), 
transferred into 1.5-ml tubes, and washed in cold PBS again before 
resuspension in radioimmunoprecipitation buffer, 100 l per T175 
flask [50 mM tris (pH 8), 1% NP-40, 0.1% SDS, 150 mM NaCl, 0.5% 
sodium deoxycholate, 5 mM EDTA, 1 mM phenylmethylsulfonyl 
fluoride]. Samples were shaken at 4°C for 30 min before being spun 
at 500g for 10 min. Supernatants were mixed in SDS sample buffer and 
run in parallel with vesicle samples in SDS-PAGE. For loading con-
trol, Western blots were re-probed using a mouse anti–glyceraldehyde- 
3-phosphate dehydrogenase antibody (Sigma-Aldrich Chemie GmbH), 
followed by anti-mouse HRP (Sigma-Aldrich Chemie GmbH).
Transient transfection–based cell-cell fusion assay
Fusion activity of the different HSV-1 gB constructs was determined 
after transient transfection of RK13 cells as described recently (41). 
Briefly, cells were transfected with 200 ng each of the expression 
plasmids for enhanced green fluorescent protein (EGFP) (pEGFP- N1; 
Clontech), nectin-1, and HSV-1 glycoproteins gD, gL, gH, and gB 
or mutant gB in 100 l of Opti-MEM using 1 l of Lipofectamine 
2000. Twenty-four hours after transfection, the cells were fixed with 
3% paraformaldehyde and analyzed using an Eclipse Ti-S fluores-
cence microscope and NIS-Elements Imaging Software (Nikon). Fusion 
activity was determined by multiplication of the number of syncytia by 
the mean syncytia area within 10 fields of view (5.5 mm2 each). Each ex-
periment was repeated four times, and average percent values of positive 
control transfections as well as standard deviations were calculated.
MD simulations
Starting structures were generated by taking the DIII helix (residues 
500 to 573) from the HSV-1 (postfusion) gB (2GUM) (6) structure. 
The helix was centered in a simulation cell large enough that no edge 
was closer than 2.0 nm from the protein, and subsequently solvated 
with SPC/E (extended simple point charge model) water (42) and 
neutralizing monovalent ions to a concentration of 0.15 M. Each 
complete system was first energy minimized using 50,000 steps of 
steepest descent energy minimization. It was then equilibrated in 
the NVT (number of particles, volume, temperature) ensemble at 300 K 
to bring the system up to the simulation temperature. The output 
was continued into the NPT (number of particles, pressure, tem-
perature) ensemble equilibration at the same temperature and 1 atm 
isotropic pressure to bring the pressure to that required for the pro-
duction simulation. Last, the NPT output was used as the starting 
structure and velocity distribution for the production MD simula-
tions. MD simulation parameters: Leap-frog integrator was used to 
model the equations of motion, with a 2-fs time step. LINCS (linear 
constraint solver) was used to constrain all bonds involving hy-
drogen. Nonbonded van der Waals interactions were cut off using 
the Verlet scheme with a 1.0-nm cutoff, while electrostatics were 
modeled using the Particle Mesh Ewald (43) method with an order of 
4 and 0.16 Fourier spacing. Temperature was coupled to an external 
velocity-rescale thermostat at 300 K, protein and nonprotein com-
ponents being coupled separately, with a 0.1-ps time constant. For 
NPT equilibration and MD, pressure was isotropically set at 1 atm 
by coupling to a Parrinello- Rahman barostat with a 2.0-ps time 
constant. Equilibration simulations were run for 100 ps with posi-
tion restraints applied to protein backbone atoms. The production 
MD simulations were run for 100 ns with no position restraints on 
the protein. All simulations were performed using Gromacs 5.1.2 
(44). Local helix bending angles were determined using HELANAL 
(45), implemented within MDAnalysis (46, 47) using a sliding win-
dow of four contiguous  carbons to compute local helix axes and 
origins over the length of the entire helix, one  carbon at a time. 
Bending angles are the angles between successive local helix axes. 
Local bending angle plots were generated with Matplotlib (48).
Cryo-EM to determine vesicle size distributions
For grid preparation, 3.5 l of vesicles were mixed with 10-nm gold 
fiducials on Quantifoil R2/1 grids and plunge-frozen in a propane/
ethane mixture using a manual plunge freezer. Microscopy was per-
formed using a Tecnai F30 “Polara” microscope (FEI Thermo Fisher 
Scientific) at 300 kV equipped with a Quantum 964 post-column 
energy filter (Gatan) operated in zero-loss imaging mode. Images 
were recorded on a 4k × 4k K2 Summit electron detector with a 
calibrated pixel size of 0.14 nm at the specimen level. Transmission 
images were recorded using SerialEM (49) at a −3-m defocus. Vesicle 
diameters were measured in 3dmod.
Tomogram acquisition
Tomograms were collected in 3° increments either bidirectionally on 
Tecnai F30 “Polara” or using a dose-symmetric scheme (50) on Titan 
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Krios (FEI/Thermo Fisher Scientific) at 300 kV both with a 70-m C2 
aperture and post-column Quantum energy filter operated in zero-loss 
mode using an energy slit of 20 eV and K2 Summit direct electron detec-
tor in counting mode (Gatan). SerialEM (49, 51) was used for automated 
data collection. Please see table S2 for data acquisition parameters.
Image processing
Frames were aligned using Unblur (52) or SerialEM plugin (51). 
Defocus estimation was performed using IMOD ctfplotter (53), 
phase flipping was performed using NovaCTF (54) or ctfphaseflip, 
and dose weighting was performed using IMOD mtffilter. Tomograms 
were aligned using IMOD etomo (53) and subsequently reconstructed 
using NovaCTF, with the exception of eight tomograms that were 
used etomo’s local alignment. Two sets of tomograms were used with 
all available tilts (all-tilt tomograms) or using tilt series that had 
tilts collected above 20° and below −20° replaced by images filled with 
the tilt series mean intensity (low-tilt tomograms). Tomograms were 
binned two, four, or six times using IMOD binvol and filtered 
for visual inspection and manual picking in 3dmod (IMOD) using 
bfilter (55).
Sub-volume averaging
Tomogram reconstruction was performed using IMOD (53) and 
NovaCTF (54). PEET (55, 56) was used for SVA together with a set 
of bespoke scripts based on TEMPy (57) for particle coordinate ma-
nipulation. Two independent reference volumes were generated by 
aligning and symmetrizing particles from a small subset of tomo-
grams binned six times and used for subsequent alignment of all 
particles within each half-dataset. All-tilt tomograms were replaced 
by low-tilt tomograms after convergence of two times binned data. 
Only translations were allowed for alignment of low-tilt tomograms 
due to a larger missing wedge. Alignment was initially focused on 
the whole protein including the membrane bilayer and then re-
stricted to the protein ectodomain. Angles were refined at this stage 
using all-tilt tomograms, followed by further low-tilt translation re-
finement. Particle models were manually cleaned using UCSF (Uni-
versity of California, San Francisco) Chimera (29), and corresponding 
pairs of particles and orientations were removed from PEET models 
and initial motive lists, followed by a final alignment using unbinned 
tomograms. An average volume containing the protein CTD was 
obtained by expanding the alignment box and mask and allowing 
translation refinement. FSC (Fourier shell correlation) was calculat-
ed using bresolve (Bsoft) between the half-dataset averages masked 
with a binary mask using bmask (Bsoft) and a soft-edge mask using 
clip (IMOD) to avoid mask correlation. Because of a slight misalign-
ment between the half-dataset averages, one half- map was aligned to 
the other in Chimera before FSC calculation. The 0.143 FSC cutoff 
was used to determine the ectodomain (9.0 Å) and the whole protein 
(10.1 Å) resolution. The final average containing both half-datasets 
(46,067 particles – post C3 symmarization) was generated by merg-
ing particles after manual cleaning and aligning positions to the sum 
of the half-dataset averages. The experimental B factor was estimated 
using embfactor (58) to ~400 Å2; a more conservative value of −300 Å2 
was applied to combined average using bfilter (Bsoft).
Model building
Rigid-body fitting of individual domains of the postfusion gB crys-
tal structure (5V2S) (14) was performed using Chimera. The fit 
for DIV was used as a starting and reference point for symmetriza-
tion of protomer models. Fitting of domains was refined using 
Namdinator (30) with a sharpened SVA map and default parame-
ters (20,000 steps). Visualization and figure generation were per-
formed in Chimera or ChimeraX (59). Cross-correlations for each 
domain were calculated using the “Fit in Map” command in UCSF 
Chimera (29) for both: models generated by rigid-body fitting and 
MD flexible fitting (29), with a map simulated from the relevant 
atoms using a nominal resolution of 10 Å. The SCCC (segment- 
based cross correlation coefficient) was calculated using TEMPy 
(57), as implemented in the CCP-EM (Collaborative Computational 
Project for Electron cryo- Microscopy) software suite (60).
Expression and crystallization of recombinant HSV-1  
gB H516P ectodomains
The synthetic gene, codon-optimized for protein expression in in-
sect cells, and coding for HSV-1 gB H516P residues 31 to 730 was 
cloned into the pT350 vector (61) between the vector-encoded Bip 
signal peptide that drives protein secretion and a double strep tag. 
The gB ectodomains were produced in S2 Drosophila cells using 
standard methods (62). The protein was purified on Strep-Tactin 
affinity resin and by size exclusion chromatography using Superdex 
200 16/60 column and 10 mM tris (pH 8) and 50 mM NaCl as run-
ning buffer. The protein was concentrated to 6.4 mg/ml and crystal-
lized in 0.1 M tris (pH 8), 18% ethanol at the Institut Pasteur core 
facility for crystallization (63). They were flash-frozen in liquid ni-
trogen in cryosolution containing 0.1 M tris (pH 8), 20% ethanol.
X-ray data collection and structure determination of HSV-1 
gB H516P ectodomain
The diffraction data were collected at the SOLEIL synchrotron source 
Proxima 2 beamline and processed with X-ray detector software 
(XDS) (64). The crystals belong to P321 space group, with cell di-
mensions a = 118 Å, b = 118 Å, c = 162 Å,  =  = 90°, and  = 120°. 
The data were cut off at 6.4 Å [with cross correlation (CC)(1/2) 
value of 0.601 for the high-resolution shell] and used for molecular 
replacement done with Phaser (65) and the HSV1 gB structure (6) 
[Protein Data Bank (PDB) 2GUM] as the search model. One round 
of refinement was done using BUSTER (66).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/39/eabc1726/DC1
View/request a protocol for this paper from Bio-protocol
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